Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

NCT00657150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2055

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Enoxaparin
DRUG: Dabigatran etexilate

Sponsor

Boehringer Ingelheim